In cancer patients, IL-6 induces development and immunosuppressive function of MDSCs and tumor-associated macrophages through signal transducer and activator of transcription 3 (STAT3)-mediated mechanism [15,26,27,28,29]. Here, IL6 is linked to neoplasm.